- Parties: The plaintiff was Aralez Pharmaceuticals Canada Inc. The defendants were Taro Pharmaceuticals Inc. and APR Applied Pharma Research SA.

- Subject Matter: This was a patent enforcement action under the Patented Medicines (Notice of Compliance) Regulations. The plaintiffs alleged patent infringement and initiated proceedings to prevent the defendant from launching a generic version of their patented medicine. The case is ongoing.

- Date: The hearing was set on August 21, 2025.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.